Alzheimer's Therapy Market Size, Share and Industry Forecast 2023

The global alzheimer's therapy market size was valued at USD 4,211.8 million in 2022 and is poised to grow at a significant CAGR of 16.3% during the forecast period 2023-29. The primary drivers of the expansion of the global Alzheimer's therapy market include the increasing prevalence of Alzheimer's disease and increasing aging population across the globe. Advancement of technology and innovation of new drugs is expected to drive the growth of Alzheimer's disease market.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/alzheimer-s-therapy-market

The alzheimer's therapy market is segmented based on drug class, distribution channel, and geography.
Based on the Drug Class, the market is segmented into the following:
• Cholinesterase Inhibitors
• N-Methyl D-Aspartate Antagonist
• Combination Drugs
• Others

Based on the Distribution Channel, the market is segmented into the following:
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Cholinesterase Inhibitors Segment is expected to Dominate the Alzheimer's Therapy Market
Based on the drug class, the global Alzheimer's Therapy market is segmented into Cholinesterase inhibitors, N-Methyl D-Aspartate Antagonist, Combination Drugs, and Others. The Cholinesterase Inhibitor segment is expected to account for a larger revenue share in the global Alzheimer's therapy market. Cholinesterase inhibitors are class of drugs which stops the breakdown of acetylcholine neurotransmitter. Cholinesterase inhibitors blocks the action of cholinesterase enzyme which is responsible for the breakdown of acetylcholine neurotransmitter in the body. The cholinesterase inhibitors have shown an drastic results in the treatment of Alzheimer's in the historic years, hence it is expected to dominate the Alzheimer's therapy market in this segment in the forecasted years.

North America Alzheimer's Therapy Market
The North America Alzheimer's therapy market is expected to increase over the forecast period due to the in number of Alzheimer's patients in this region and increase in geriatric population in this region. The presence of several market key players and their rising investments in the research and development activities in this region is expected to drive the Alzheimer's therapy market in this region. Moreover, new launches of novel and innovative drugs for the treatment of Alzheimer's disease is expected to fuel the growth of Alzheimer therapy market at a significant rate in this region.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players.
The global Alzheimer's Therapy market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region. For instance, In October 2022, Cyclo Therapeutics Inc. commenced their phase II study of their pipeline drug 'Trappsol Cyclo'.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=656727

Key players profiles in the Alzheimers Therapy Market report are Eisai Co., Ltd., Novartis AG., AbbVie Inc., Adamas Pharmaceuticals, Inc., H. Lundbeck A/S., Biogen, AC Immune., Cyclo Therapeutics Inc., F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited., Johnson & Johnson Services, Inc., TauRx Pharmaceuticals Ltd.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.